LBA25 Randomized phase III trial of ramucirumab in combination with TAS102 (Trifluridin/Tipiracil) vs. TAS102 monotherapy in heavily pretreated metastatic colorectal cancer: The RAMTAS/IKF643 trial of the German AIO (AIO-KRK-0316).
Saved in:
| Title: | LBA25 Randomized phase III trial of ramucirumab in combination with TAS102 (Trifluridin/Tipiracil) vs. TAS102 monotherapy in heavily pretreated metastatic colorectal cancer: The RAMTAS/IKF643 trial of the German AIO (AIO-KRK-0316). |
|---|---|
| Authors: | Kasper-Virchow, S.1 (AUTHOR), Hofheinz, R.D.2 (AUTHOR), Stintzing, S.3 (AUTHOR), Dechow, T.N.4 (AUTHOR), Ettrich, T.J.5 (AUTHOR), Sinn, M.6 (AUTHOR), Roderburg, C.7 (AUTHOR), Fischer von Weikersthal, L.8 (AUTHOR), Graeven, U.9 (AUTHOR), Mueller, C.10 (AUTHOR), Meiler, J.11 (AUTHOR), Stein, A.12 (AUTHOR), Modest, D.P.13 (AUTHOR), Pauligk, C.14 (AUTHOR), Virchow, I.15 (AUTHOR), Siveke, J.T.16 (AUTHOR), Al-Batran, S-E.17 (AUTHOR), Schuler, M.H.H.18 (AUTHOR), Goetze, T.O.19 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1218-S1218. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.2264 |
